| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 295,3 k € | -9.0% | 324,7 k € | +0.1% | 324,5 k € | +9.0% | 297,8 k € | -4.2% | 310,7 k € | +1.5% | 306,1 k € | -1.3% | 310,2 k € | +66.3% | 186,5 k € | -23.6% | 244,1 k € | +5.6% | 231,2 k € | -9.2% | 254,5 k € | -15.5% | 301,2 k € | +52.3% | 197,8 k € | +2.7% | 192,6 k € | +15.3% | 167,0 k € | +89.1% | 88,3 k € | -13.7% | 102,3 k € | |
| EBITDA | 291,1 k € | +6.1% | 274,3 k € | -14.5% | 321,0 k € | +9.1% | 294,2 k € | -4.3% | 307,4 k € | +1.3% | 303,5 k € | -0.8% | 306,0 k € | +68.1% | 182,0 k € | -24.2% | 240,2 k € | +5.6% | 227,5 k € | -9.5% | 251,4 k € | -15.7% | 298,3 k € | +52.3% | 195,9 k € | +2.5% | 191,2 k € | +14.8% | 166,5 k € | +91.6% | 86,9 k € | -13.9% | 101,0 k € | |
| Operating profit | 289,9 k € | +6.8% | 271,5 k € | -11.8% | 307,7 k € | +16.1% | 265,1 k € | -2.2% | 271,1 k € | +2.3% | 264,9 k € | -3.5% | 274,5 k € | +83.7% | 149,4 k € | -31.2% | 217,0 k € | +6.2% | 204,3 k € | -12.2% | 232,7 k € | -11.2% | 262,0 k € | +45.6% | 179,9 k € | +13.2% | 158,9 k € | +32.7% | 119,8 k € | +116.1% | 55,4 k € | -21.8% | 70,9 k € | |
| Profit/loss | 201,3 k € | +14.0% | 176,6 k € | -10.7% | 197,8 k € | +3.6% | 190,9 k € | -0.6% | 192,0 k € | +0.1% | 191,9 k € | +1.7% | 188,6 k € | +73.3% | 108,8 k € | -25.9% | 146,9 k € | +2.1% | 143,8 k € | -10.0% | 159,9 k € | -9.4% | 176,5 k € | +36.1% | 129,8 k € | +17.6% | 110,3 k € | +24.2% | 88,8 k € | +110.9% | 42,1 k € | -18.0% | 51,4 k € | |
| Equity | 3,0 M € | +7.2% | 2,8 M € | +6.8% | 2,6 M € | +8.2% | 2,4 M € | +25.6% | 1,9 M € | +9.6% | 1,7 M € | +12.5% | 1,5 M € | +11.9% | 1,4 M € | +8.6% | 1,3 M € | +13.1% | 1,1 M € | +14.7% | 977,0 k € | +19.6% | 817,1 k € | +27.6% | 640,6 k € | +25.4% | 510,8 k € | +27.5% | 400,5 k € | +28.5% | 311,7 k € | +15.6% | 269,6 k € | |
| Total assets | 3,0 M € | +7.0% | 2,8 M € | +2.8% | 2,7 M € | +6.2% | 2,6 M € | +17.4% | 2,2 M € | +6.6% | 2,0 M € | +6.2% | 1,9 M € | +9.4% | 1,8 M € | +1.8% | 1,7 M € | +7.0% | 1,6 M € | +7.0% | 1,5 M € | +5.7% | 1,4 M € | +9.6% | 1,3 M € | +55.7% | 838,7 k € | +33.4% | 628,7 k € | +85.3% | 339,3 k € | +12.9% | 300,6 k € | |
| Cash | 439,1 k € | +8.9% | 403,2 k € | -45.8% | 743,8 k € | +40.4% | 529,7 k € | +5.9% | 500,3 k € | +60.0% | 312,7 k € | -39.9% | 520,2 k € | +37.3% | 378,8 k € | -12.2% | 431,5 k € | +38.0% | 312,7 k € | +165.6% | 117,8 k € | +317.0% | 28,2 k € | -12.5% | 32,3 k € | — | 47,8 k € | +34.6% | 35,5 k € | -57.2% | 82,9 k € | |||
| Debts | 34,5 k € | -12.1% | 39,2 k € | -71.8% | 139,2 k € | -20.9% | 176,0 k € | -37.7% | 282,7 k € | -10.3% | 315,1 k € | -18.8% | 388,0 k € | +0.6% | 385,7 k € | -17.0% | 464,4 k € | -6.7% | 497,6 k € | -7.1% | 535,7 k € | -12.7% | 613,8 k € | -7.7% | 665,2 k € | +102.8% | 327,9 k € | +43.7% | 228,2 k € | +725.9% | 27,6 k € | -10.9% | 31,0 k € | |
Private limited company · Izegem · incorporated on 02/11/2000
Private limited company profitable and well capitalised. Cash position rising (+8.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
VANDENBROUCKE FRANK UROLOGIE is a Private limited company incorporated in 2000. Its main activity is: Specialist medical practice activities. Its registered office is in Izegem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette